Glaukos Corporation
GKOS
Classificação em ações
#2115
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Preço da ação
$164.43
Última sincronização: 2026-10-16
Valor de mercado
$9.70B
Variação (1 dia)
-0.95%
Variação (1 ano)
88.63%
País
US
Negociar Glaukos Corporation (GKOS)
Categoria
Healthcare
EPS de Glaukos Corporation (GKOS)
EPS em June 2026 TTM: $-3.25
De acordo com os últimos relatórios financeiros e o preço das ações da Glaukos Corporation, o EPS atual da empresa (TTM) é $-3.25. No final de 2023, a empresa teve um EPS de $-2.78, um aumento em relação a ao EPS de 2022, que foi de $-2.09.
Histórico de EPS da Glaukos Corporation de 2012 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2026 (TTM) | $-3.25 | 17.33% |
| 2024 | $-2.77 | -0.36% |
| 2023 | $-2.78 | 33.01% |
| 2022 | $-2.09 | 95.33% |
| 2021 | $-1.07 | -60.37% |
| 2020 | $-2.70 | -758.54% |
| 2019 | $0.41 | -210.81% |
| 2018 | $-0.37 | 13,603.70% |
| 2017 | 0.00 | -101.93% |
| 2016 | $0.14 | -106.57% |
| 2015 | $-2.13 | 334.69% |
| 2014 | $-0.49 | -3.92% |
| 2013 | $-0.51 | -94.76% |
| 2012 | $-9.73 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| $3.11 | -195.69% |
US
|
|
| $3.59 | -210.46% |
IE
|
|
| $9.73 | -399.38% |
US
|
|
| $2.48 | -176.31% |
US
|
|
| - | - |
DE
|
